ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.83
0.53%
US Tech 100
18,050.40
-0.16%
S&P 500
5,297.73
0.01%
US Dollar vs CAD
1.36095
-0.04%
Bitcoin
66,784.68
2.37%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orchard Therapeutics PLC (ORTX)

  7. Orchard Therapeutics PLC (ORTX) News

ORTX Orchard Therapeutics PLC

16.70
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Orchard Therapeutics PLC ORTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 16.70 19:00:00
Open Price Low Price High Price Close Price Previous Close
16.70
more quote information »

Recent News

Date Time Source Heading
5/07/202406:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
5/03/202406:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
3/20/202406:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
3/18/202414:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
2/14/202420:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/05/202413:39EDGAR2Form 15-12G - Securities registration termination [Section..
2/05/202406:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
2/02/202406:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
1/30/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/25/202406:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
1/24/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
1/24/202415:28EDGAR2Form POS AM - Post-Effective amendments for registration..
1/24/202415:17EDGAR2Form 8-K - Current report
1/24/202404:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
1/22/202415:10EDGAR2Form 8-K - Current report
12/19/202315:49EDGAR2Form 8-K - Current report
12/11/202306:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
12/08/202315:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/08/202315:37EDGAR2Form 8-K - Current report
11/30/202315:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/30/202315:06EDGAR2Form 8-K - Current report
11/30/202306:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
11/21/202306:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/21/202306:51EDGAR2Form 8-K - Current report
11/16/202315:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
11/13/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202306:05EDGAR2Form 8-K - Current report
11/13/202306:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
11/03/202316:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
10/26/202315:35EDGAR2Form 8-K - Current report
10/26/202306:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
10/24/202306:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
10/17/202315:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/05/202316:26EDGAR2Form DEFA14C - Additional information statement materials,..
10/05/202315:48EDGAR2Form DEFA14C - Additional information statement materials,..
10/05/202315:45EDGAR2Form DEFA14C - Additional information statement materials,..
10/05/202315:43EDGAR2Form DEFA14C - Additional information statement materials,..
10/05/202315:40EDGAR2Form DEFA14C - Additional information statement materials,..
10/05/202308:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/05/202308:05EDGAR2Form 8-K - Current report
10/05/202306:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
10/05/202302:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
9/18/202306:07EDGAR2Form 8-K - Current report
9/18/202306:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
8/31/202306:00GLOBEOrchard Therapeutics Announces Presentation of Data..
8/21/202315:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/10/202316:04EDGAR2Form S-8 - Securities to be offered to employees in employee..

Your Recent History

NASDAQ
ORTX
Orchard Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved